Free Trial
OTCMKTS:ORINY

Orion OYJ Q2 2026 Earnings Results & Report

Orion OYJ logo
$57.89 0.00 (0.00%)
As of 11/12/2026 02:59 PM Eastern

Orion OYJ reported Q2 2026 earnings on July 17, 2026. The company reported EPS of $0.58, while revenue was $606.38 million.

Earnings Announcement Details

Quarter
Q2 2026
Report Date
Time
Before Market Opens

Orion OYJ EPS Results

Actual EPS
$0.58
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Orion OYJ Revenue Results

Actual Revenue
$606.38 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Orion OYJ Q2 2026 Earnings FAQ

Orion OYJ (OTCMKTS:ORINY) reported earnings of $0.58 per share for Q2 2026. The report was announced on Friday, July 17, 2026.

Orion OYJ reported revenue of $606.38 million for Q2 2026.

Orion OYJ Earnings Headlines

Orion Oyj
Your free book is about to disappear
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel
See More Orion OYJ Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Orion OYJ? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Orion OYJ and other key companies, straight to your email.

About Orion OYJ

Orion OYJ (OTCMKTS:ORINY) is a Finnish pharmaceutical company that develops, manufactures and markets medicines for human and veterinary use. Its portfolio includes prescription and over-the-counter medicines, as well as active pharmaceutical ingredients supplied to other pharmaceutical companies.

Founded in 1917 and headquartered in Espoo, Finland, Orion has a long history in the pharmaceutical industry. The company focuses on areas including oncology, neurology and respiratory diseases, and develops some products in collaboration with international pharmaceutical partners.

Orion serves customers in Finland and other European markets, while partnerships and product sales extend its reach to markets around the world. Its operations also include research and development, manufacturing and the commercialization of medicines.

View Orion OYJ Profile